Paragon Associates & Paragon Associates II Joint Venture’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-35,000
Closed -$580K 25
2017
Q2
$580K Buy
35,000
+25,000
+250% +$414K 0.66% 13
2017
Q1
$138K Buy
+10,000
New +$138K 0.15% 20